Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,698 | -3,241 | -2,049 | -609 | -5,506 |
| Depreciation Amortization | 10 | 8 | 5 | 3 | 14 |
| Accounts payable and accrued liabilities | 586 | 417 | 313 | 146 | 214 |
| Other Working Capital | 1,150 | 1,043 | 755 | 263 | 365 |
| Other Operating Activity | 899 | 844 | 245 | -28 | 2,289 |
| Operating Cash Flow | $-1,053 | $-929 | $-731 | $-226 | $-2,624 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 258 | N/A | N/A | N/A | 688 |
| Common Stock Issued | 600 | 600 | 600 | N/A | N/A |
| Other Financing Activity | 0 | 131 | 28 | 18 | 2,130 |
| Financing Cash Flow | $858 | $731 | $628 | $18 | $2,818 |
| Beginning Cash Position | 217 | 217 | 217 | 217 | 23 |
| End Cash Position | 22 | 18 | 113 | 9 | 217 |
| Net Cash Flow | $-195 | $-199 | $-104 | $-208 | $194 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,053 | -929 | -731 | -226 | -2,624 |
| Free Cash Flow | -1,053 | -929 | -731 | -226 | -2,624 |